TUESDAY, May 29, 2018 -- Walking, running, crouching, lifting and exercising the legs is critical to optimizing your nervous system's ability to function, new animal research suggests.
Based on work with mice, the finding highlights the complexity of the brain-muscle connection. And it suggests that the nervous system communication moving from an individual's large leg muscles up to the brain is just as important as communication that originates in the brain before heading down to the muscles.
THURSDAY, May 24, 2018 -- Because vertigo can have many causes, treating it can be difficult, but researchers have identified a new type that may be effectively treated with medication.
"These conditions can be difficult to diagnose and quite debilitating for people, so it's exciting to be able to discover this new diagnosis of a condition that may respond to treatment," said Dr. Ji-Soo Kim, a researcher at Seoul National University in South Korea.
WEDNESDAY, May 16, 2018 -- Less appears to be more when it comes to treating epilepsy with the marijuana extract cannabidiol, a new clinical trial suggests.
Patients taking a 10-milligram (mg) daily dose of pharmaceutical grade cannabidiol (CBD) experienced nearly as great a reduction in seizures as patients on 20 mg, and with fewer side effects, said lead researcher Dr. Orrin Devinsky. He is director of NYU Langone's Comprehensive Epilepsy Center in New York City.
FRIDAY, May 18, 2018 -- The millions of Americans who suffer from migraine may have a new source of hope -- the first drug aimed at preventing the headaches gained U.S. Food and Drug Administration approval on Thursday.
Researchers have found that the injected drug, called Aimovig (erenumab), can prevent migraines if other treatments have failed to do so.